Pulsed Field Ablation for the Interventional Treatment of Atrial Fibrillation. A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin

Pulsed field ablation has emerged as a novel non-thermal treatment modality with a distinct safety profile for the interventional treatment of atrial fibrillation. By inducing irreversible electroporation, pulsed field ablation achieves myocardial ablation while preserving surrounding structures such as nerves, vasculature, and the esophagus. This European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) scientific statement, endorsed by major international societies, reviews the biophysics, technology, clinical evidence, workflow, safety, and training aspects of pulsed field ablation. Randomized trials demonstrate comparable efficacy to radiofrequency and cryoballoon ablation, with advantages in safety and efficiency. The statement provides practical advice for clinical implementation, operator training, and identifies key gaps in evidence and priorities for future research and innovation.

Authors

Institutions

Publication Details

Journal
EP Europace
Published
2026-04-10
DOI
https://doi.org/10.1093/europace/euag080
Citations
1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
19.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulsed Field Ablation for the Interventional Treatment of Atrial Fibrillation. A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin

Helmut Pürerfellner, Stylianos E. Tzeis, Bradley Wilsmore, Heiko Lehrmann et al.
1 citations
EP Europace
Atrial Fibrillation Management and Outcomes
19.82
article

Pulsed Field Ablation for the Interventional Treatment of Atrial Fibrillation. A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin

Helmut Pürerfellner, Stylianos E. Tzeis, Bradley Wilsmore, Heiko Lehrmann, Jonathan Paul Piccini, JKR Chun, Kars Neven, Ante Anić, Raphaël Rosso, Hiroshi Tada, Atul Verma, Martin Huth Ruwald, Michael Kühne, Pierre Jaı̈s, Damijan Miklavčič, Patrick Badertscher, Josef Kautzner, Andrea Sarkozy, Antonio Dello Russo, Jason G. Andrade, Arian Sultan, Tobias Reichlin, Armando Pérez-Silva, Claire A Martin, Jose Luis Merino, Andrea Natale, Daniel Scherr
article en
1 citations

Abstract

Pulsed field ablation has emerged as a novel non-thermal treatment modality with a distinct safety profile for the interventional treatment of atrial fibrillation. By inducing irreversible electroporation, pulsed field ablation achieves myocardial ablation while preserving surrounding structures such as nerves, vasculature, and the esophagus. This European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) scientific statement, endorsed by major international societies, reviews the biophysics, technology, clinical evidence, workflow, safety, and training aspects of pulsed field ablation. Randomized trials demonstrate comparable efficacy to radiofrequency and cryoballoon ablation, with advantages in safety and efficiency. The statement provides practical advice for clinical implementation, operator training, and identifies key gaps in evidence and priorities for future research and innovation.

EP Europace
University of Fukui (JP), Marche Polytechnic University (IT), University of Copenhagen (DK), Heart Rhythm Society (US), Université de Bordeaux (FR), University of Ljubljana (SI), Medical University of Graz (AT), Royal Papworth Hospital (GB), Tel Aviv Sourasky Medical Center (IL), University Hospital of Bern (CH), University Medical Center Freiburg (DE), McGill University Health Centre (CA), University Hospital of Basel (CH), Vancouver General Hospital (CA), Clinical Research Institute (US), Cardiovascular Center Bethanien (DE), Tweed Shire Council (AU), Heart Foundation (US), Hospital La Paz Institute for Health Research (ES), Hôpital Cardiologique du Haut-Lévêque (FR), Hospital Regional de Concepción (CL), Asklepios Klinik St. Georg (DE), Universitair Ziekenhuis Brussel (BE), Institute of Clinical and Experimental Medicine (CZ), Krankenhaus der Elisabethinen (AT), Mitera Hospital (GR), Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE), Klinički Bolnički Centar Split (HR), Texas Cardiac Arrhythmia (US), Alfried Krupp Hospital (DE), McGill University (CA), Universidad Autónoma de Madrid (ES), University of Split (HR)
Industry, innovation and infrastructure
Openalex Percentile: Top 1%
Atrial Fibrillation Management and Outcomes
19.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.